Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
KNSA compared with HRTX: revenue, margins and what each company keeps, and the suppliers and customers both name
KNSA
Kiniksa Pharmaceuticals International, plc
Change
Mkt cap
Revenue
Revenue
HRTX
Heron Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
KNSA
Kiniksa Pharmaceuticals International, plc
vs
HRTX
Heron Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
KNSA, solid
HRTX, dashed
KNSA
Kiniksa Pharmaceuticals International, plc
Change
92.17
· pre 92.18
· delayed
Mkt cap
$7.2B
Revenue
$286M
Q3 FY26
Revenue
$678M
FY25
HRTX
Heron Therapeutics, Inc.
Change
0.28
· pre 0.28
· delayed
Pre-market
Oct 30 '26
delayed
Mkt cap
$52.7M
Revenue
$38M
Q2 FY26
Revenue
$155M
FY25
vs
Compare
Pre-market
Oct 30 '26
delayed
KNSA
Kiniksa Pharmaceuticals International, plc
vs
HRTX
Heron Therapeutics, Inc.
92.17
pre 92.18
delayed
Price
0.28
pre 0.28
delayed
$7.2B
Mkt cap
$52.7M
Q3 FY26
$286M
Revenue
$38M
Q2 FY26
FY25
$678M
Revenue
$155M
FY25
Change
Change
KNSA
92.17
vs
HRTX
0.28
Pre-market
Oct 30 '26
delayed